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MitofusinFetal cardiomyocyte adaptation to low levels of oxygen in utero is incompletely understood, and is of interest as
hypoxia tolerance is lost after birth, leading to vulnerability of adult cardiomyocytes. It is known that cardiacmi-
tochondrialmorphology, number and function change signiﬁcantly following birth, although the underlyingmo-
lecular mechanisms and physiological stimuli are undeﬁned.
Here we show that the decrease in cardiomyocyte HIF-signaling in cardiomyocytes immediately after birth acts as
a physiological switch drivingmitochondrial fusion and increased postnatal mitochondrial biogenesis. We also in-
vestigated mechanisms of ATP generation in embryonic cardiac mitochondria. We found that embryonic cardiac
cardiomyocytes rely on both glycolysis and the tricarboxylic acid cycle to generate ATP, and that the balance be-
tween these two metabolic pathways in the heart is controlled around birth by the reduction in HIF signaling.
We therefore propose that the increase in ambient oxygen encountered by the neonate at birth acts as a key phys-
iological stimulus to cardiac mitochondrial adaptation.
Crown Copyright © 2014 Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Fetal cardiomyocytes are adapted to function in low levels of oxygen
in utero, whereas adult cardiomyocytes are extremely vulnerable to
hypoxia, as evidenced by high rates of mortality and morbidity caused
by ischemic heart disease [1]. Shortly after birth, cardiomyocytes lose
their capability to adapt to hypoxic conditions. The process underlying
this postnatal maturational process is not understood.
It is thought that fetal cardiomyocytes generate ATP predominantly
by glycolysis and glucose oxidation [2]. At birth, ambient oxygen levels
increase sharply as the neonate emerges into the terrestrial environ-
ment. Immediately after birth, cardiac output, and therefore cardiac
energy requirements, increase rapidly [3]. This increase is achieved
through switching fromglycolysis to β-oxidation of lipids, which gener-
ates larger amounts of ATP per unit of substrate than glycolysis [2,4],
and is accompanied by an increase in mitochondrial number [5].IF, Hypoxia inducible factor;
mma co-activator 1; TMRM,
.
Biology, MRC National Institute
, United Kingdom NW7 1AA.
r Ltd. This is an open access article uRecently, our understanding of molecular mechanisms controlling
postnatal cardiac bioenergetics and mitochondrial remodeling has ad-
vanced, but physiological stimuli controlling these processes remain to
be deﬁned. This information is of interest with respect to future strategies
to protect adult cardiomyocytes in ischemic heart disease and to increase
our understanding of human cardiac conditions presenting around birth.
Mitochondrial biogenesis is upregulated following birth as a conse-
quence of increases in Pgc1α/β expression [5], although the physiologi-
cal stimuli for this are yet to be described. Furthermore, it is recognized
that mitochondrial morphology is intimately linked with function, fu-
sion of mitochondria being associated with increased β-oxidation of
lipid [6,7]. Fetal mitochondria are “fragmented” in appearance, whereas
postnatal mitochondria appear elongated, consistent with the metabol-
ic switch occurring in the heart ﬂowing birth [2]. Mitofusin proteins
(MFNs) are implicated in the control of postnatal mitochondrial fusion,
although, again, the relationship to physiological changes around birth
is not known [8].
We investigated the mechanisms controlling neonatal cardiac mito-
chondrial remodeling at birth. Immediately following birth, ambient
levels of oxygen encountered by the neonate increase signiﬁcantly [9].
We have recently shown that the postnatal decrease in cardiac hypoxia
signaling controls the lipid metabolizing gene expression program [10]
and postnatal remodeling of the cardiac conduction system [11].nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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of hypoxia inducible factor (HIF) leads to diminished respiratory capac-
ity and inhibited mitochondrial biogenesis [12,13]. We therefore
hypothesized that the increase in cardiac oxygen tension acts, via HIF
signaling, as a developmental “switch”, driving postnatal maturation
of the heart. We investigated the effects of the reduction in hypoxia
signaling following birth on the structure and function of cardiac
mitochondria.
2. Results
2.1. The morphology of cardiac mitochondria around birth is dependent on
hypoxia signaling
In situ measurement of mitochondrial function in utero is not cur-
rently possible without exposing the cells to oxygen, leading to artifacts
due to oxygen-induced maturational processes. We therefore studied
hearts from mice born into normobaric hypoxia (Fi02 10%) and αMHC-
Cre::VHL(ﬂ/ﬂ) mice which maintain constitutively high levels of HIF sig-
naling in the presence of normoxia [14] in order to inhibit postnatal
maturational processes dependent on postnatal reductions in HIF sig-
naling. We also generated stable HL1 cell lines transfected with an
shRNA construct directed against VHLmRNA, which has a similar effect
of stabilizing HIF expression in normoxia (Supplementary Fig. 1).
Perinatal changes inmitochondrial morphology have been observed
in themouse [15] and rabbit [16] from day 3 onwards and in the guinea
pig [17] sheep [18], andmouse [8] aroundbirth. These studies used elec-
tron microscopy, and consistently observed a shift in mitochondrial
morphology from many small and ovoid to fewer long and rectangular
mitochondria with an increase in proximity between mitochondria
and themyoﬁbrils with time after birth. In concordancewith these pre-
viously published studies, we observed thatmitochondria change shape
from small and round before birth to larger and rectangular following
birth (Fig. 1A and Supplementary Fig. 2). We estimated that percentage
area occupied by mitochondria in the cell increases from E16.5 (10%) to
P10.5 (34%), with the largest increase occurring in the ﬁrst few days
after birth between P0.5 and P2.5 (Fig. 1B). We observed that the
mitochondrial cristae become more dense and uniform between E16.5
and P10.5, with an observable decrease in glycogen storage granules
sequentially from E16.5 to P10.5 and lipid droplets observed on micro-
graphs from theday of birth onwards (P0.5) (Fig. 1C and Supplementary
Fig. 2). We noted that mitochondrial morphology changes during the
perinatal period. Mitochondrial matrix in P2.5 mitochondria appears
less dense, and sarcomeres more dense and deﬁned on EMs compared
with E18.5 mitochondria (Fig. 1D and Supplementary Fig. 2).
We went on to examine whether perinatal changes in cardiac mito-
chondrial morphology are dependent on changes in ambient oxygen
levels and hypoxia signaling immediately following birth. We found
that interpreting mitochondrial morphology in electron micrographs
was difﬁcult, due to plane of sectioning issues. Therefore, we used pri-
mary cultures of cardiomyocytes, which enable the use of vital dyes to
assess mitochondrial morphology more sensitively than electron mi-
croscopy (Fig. 2A). Primary culture of embryonic cardiac cells involves
removal from a hypoxic environment in vivo and exposure to potential-
ly artifactually high levels of oxygen in culture. We therefore assessed
the effect of cardiomyocyte culture time on fusion phenotype of the
heart cells. We digested and plated E18.5 embryonic hearts and found
that the length of time in culture increased the proportion of fused mi-
tochondria until 8 h post-plating (p= 0.004) (Fig. 2B). At a culture time
of 18 h the association reversed. This emphasizes the difﬁculty in inter-
pretation of mitochondrial morphology after prolonged periods of cell
culture. Cardiomyocyte viability was not compromised by 45-min incu-
bation with MitoTracker dye: at 24 h after MitoTracker treatment, we
observed adherent cells, often displaying synchronized beating.
Observers blinded to their origin examined primary cell cultures of
cardiomyocytes, after 45-min of MitoTracker dye treatment in cellsonehour after plating.We found an increase in the proportion of cardiac
cells exhibiting mainly fused mitochondria from E18.5 to P10.5.We ob-
served an increase in the numbers of fused mitochondria after birth
with only 27% mitochondria being fused at E18.5 compared to 62%
fused at P2.5 (p = 0.05) (Fig. 2C).
At birth, the mammalian embryo encounters a sharp increase in am-
bient oxygenation [9]. We have previously shown that cardiac levels of
HIF1α protein, a key mediator of hypoxia signaling fall, but are elevated
in neonatal hearts homozygous null for VHL [10]. We therefore investi-
gatedwhether neonatal changes in cardiacHIF signaling drive the chang-
es in cardiac morphology, number and function in the neonatal heart.
To assess the impact of hypoxia signaling on mitochondrial mor-
phology we examined electron micrographs of hearts from postnatal
day 10.5 (P10.5) αMHC-Cre::VHL(ﬂ/ﬂ) mice. Mitochondria from αMHC-
Cre::VHL(ﬂ/ﬂ) mice appeared immature with respect to controls
(Fig. 2D). The image in Fig. 2D is taken from a αMHC-Cre heart (consti-
tutive cre expressing), which is on a C57BL/10 background as opposed
to the (CBA/Ca × C57BL/10) strain used for the wild-type analysis
outlined in Fig. 1 and Supplementary Fig. 2. This strain difference
could explain the different mitochondrial morphology observed be-
tween these two images. Further examples of mitochondrial morpholo-
gy are pictured in Supplementary Fig. 2. In primary cultures of
cardiomyocytes using Mitotracker dye, we found that mitochondria
from P10 αMHC-Cre::VHL(ﬂ/ﬂ) hearts exhibited signiﬁcantly higher
numbers of fragmented-appearing mitochondria compared with
controls (p b 0.001) (Fig. 2E).
2.2. Expression ofmitochondrial fusion proteins is controlled in the heart by
hypoxia signaling
Mitochondrial morphology is regulated by a family of mitochondrial
fusion and ﬁssion proteins [8,19]. We therefore investigated expression
of the fusion proteins,MFN1,MFN2 andOPA1, and ﬁssion proteins,DRP1
and FIS1 at regular intervals from E16.5 to P10.5. Western blotting of
protein extracts of ventricular tissue revealed an increase in fusion pro-
tein expression from E16.5 in a stepwise manner through to P10.5 with
the largest increase taking place between P0.5 and P2.5 in MFN1 and
MFN2 (p = 0.05) and between P2.5 and P10.5 in OPA1 (p = 0.05)
(Figs. 3A–C, representative blots in Supplementary Fig. 3). There were
no changes detectable in ﬁssion protein DRP1 and FIS1 levels over this
time period (Supplementary Fig. 4). We found that in αMHC-Cre::
VHL(ﬂ/ﬂ) hearts, expression of fusion proteinsMFN1 andOPA1was signif-
icantly reduced comparedwith controls (Pb 0.001 andp=0.04 respec-
tively, 2 tailed t tests n = 4 hearts each group) (Fig. 3D). We analyzed
cardiac mRNA expression of MFN1, MFN2 and OPA1. We found that
levels of all three mRNAs increase signiﬁcantly in the heart at birth,
and this rise is signiﬁcantly attenuated in hearts from αMHC-Cre::
VHL(ﬂ/ﬂ) neonates (Figs. 3E–G). These data suggest that postnatal HIF-
dependent mitochondrial fusion could be mediated by increases in
MFN1, MFN2 and OPA1 expression. Interestingly, no signiﬁcant change
in mRNA levels of MFN1, MFN2 and OPA1 was seen in adult inducible,
cardiac speciﬁc VHL deleting mercremer::VHL(ﬂ/ﬂ) hearts, following
5 days of tamoxifen treatment.
Wewent on to examinewhether HIF1α binds to the 5’ promoters of
MFN1, MFN2 and OPA1.We analyzed published 5’ promoter sequences
for these 5 genes, and found several canonical (A/G)CGTG HIF1α bind-
ing sites in each case (Fig. 4A). We assayed whether HIF1α directly
binds these promoters using anti HIF1α serum to perform chromatin
immunoprecipitation. We found that in each case, chromatin contain-
ing at least one HIF1α-binding site promoter fragment was enriched
20 fold over non-ampliﬁed sequences in chromatin from embryonic
αMHC-Cre control hearts (Figs. 4B-D), implying that HIF1α binds to
these sites in vivo. Chromatin Immunoprecipitation with anti-HIF1α
serum in chromatin from P2.5 control hearts revealed differences in
binding of HIF1α to several sites in these three promoters (Figs. 4E-F).
These changes were not seen in their entirety in chromatin from P2.5
Fig. 1.Mitochondrial size and number increases in cardiomyocytes after birth. (A) Average width and length of cardiacmitochondria increase as does % of the cell occupied bymitochondria
(B) following birth, as measured from electronmicrographs (n= 3 cells for each stage, p value calculated by 2-tailed t-test). Data presented as mean± SEM. (C) Transmission electron mi-
crographs, showing cardiomyocyte ultrastructure remodeling around birth. Between E18.5 and P2.5 inner mitochondrial membrane cristae become more dense and uniformly distributed
within the mitochondria, and lipid droplets are visible in cardiomyocytes after the ﬁrst day following birth (red asterisks in P2.5 image) Scale bars are 500 nm. (D) High power longitudinal
view of mitochondria from E18.5 and P2.5 wild-type mouse hearts, showing dense mitochondrial matrix in E18.5 mitochondria-Scale bars 200 nm for these two images.
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itation for each promoter site in e18 cardiac chromatin using an isotype
control IgG. We found no signiﬁcant speciﬁc binding of this antibody to
any promoter site. This implies that chromatin remodeling occurs in the
heart after birth, and that, to a degree, this remodeling may be affected
by HIF signaling.2.3. Postnatal mitochondrial biogenesis is dependent on changes in oxygen
concentration and HIF signaling
Wewent on to investigatewhether the previously observed increase
in cardiac mitochondrial mass after birth is also dependent on HIF-
signaling. We examined the mitochondrial: nuclear DNA ratio from
Fig. 2. Decreased postnatal in cardiac HIF signaling leads to an increased proportion of fused cardiomyocyte mitochondria. (A) Fluorescence micrograph of primary cultured E16.5
cardiomyocytes stained with MitoTracker showing fused (i) and fragmented (ii) mitochondrial morphology. (B) Quantiﬁcation of mitochondrial morphology in primary cultures of
cardiomyocytes at varying times after isolation and 45 min of MitoTracker staining, n = 3 each group, scored by observer blinded to the experiment. P value represents 2-tailed t test.
The proportion of fused mitochondria (open circles) increases with gestational age, and rapidly increases following birth. (C) Representative electron micrographs of cardiomyocytes
from controlαMHC-Cre and αMHC-Cre::VHL(ﬂ/ﬂ) hearts (VHL Null), showing smallermitochondriawith fewer cristae in VHL null cells. (D) Representative electronmicrographs of left ven-
tricular myocyte from control αMHC-Cre and αMHC-Cre::VHL(ﬂ/ﬂ) P2.5 hearts, showing a decreased mitochondrial number and increased proportion of fragmented mitochondria in the
VHL null cardiomyocyte compared with control (black arrowheads towards fused mitochondria, and white arrowheads towards fragmented mitochondria). (E) The proportion of
fused and fragmented mitochondria is reversed in αMHC-Cre::VHL(ﬂ/ﬂ), with more fragmented than fused mitochondria visible in VHL null P10 cardiomyocytes (n = 9, 7 and 9 in the
VHL (+/+),VHL (ﬂ/+) and VHL (ﬂ/ﬂ) groups, respectively, p value represents 2-tailed t test).
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birth) and P2.5. We found a signiﬁcant increase in the mitochondrial:
nuclear DNA ratio between E18.5 and P2.5 in wild-type mouse hearts
(Fig. 5A) (p b 0.01). This increase was not seen in hearts from αMHC-
Cre::VHL(ﬂ/ﬂ) neonates or frommice born in 10% ambient oxygen, imply-
ing that postnatal cardiac mitochondrial biogenesis is dependent on
downregulation of HIF signaling (Fig. 3A). We found that increased
postnatal expression of several mitochondrial-encoded mRNAs is also
inhibited in αMHC-Cre::VHL(ﬂ/ﬂ) hearts and hearts from P2.5 mice born
and reared in 10% oxygen (hypoxia) (Fig. 5B).
We also examined myocardial citrate synthase activity in αMHC-
Cre::VHL(ﬂ/ﬂ) and control hearts. Citrate synthase activity has been
shown to reﬂect the overall volume of mitochondria present in a
sample, a proxy for mitochondrial number [20]. We found that citrate
synthase activity increases 2.5 fold between E16.5 and P2.5 (p =
0.0003, n = 6 each group) in wild type mouse hearts consistent with
our ﬁnding of an increased proportion of cardiomyocytes occupied by
mitochondria and increased mitochondrial: nuclear DNA ratio postna-
tally (Fig. 5C). Examination of hearts from αMHC-Cre::VHL(ﬂ/ﬂ) P2.5
mice revealed no postnatal increase in citrate synthase activity,
implying that a drop in postnatal HIF signaling is required for increased
mitochondrial biogenesis.
The Pgc1α/β proteins have been shown to control neonatal mito-
chondrial biogenesis [5]. We therefore examined whether postnatal
changes in HIF signaling and/or ambient oxygen levels lead to altered
expression of Pgc1α/β.We found a postnatal increase in Pgc1αmRNA
expression following birth in control hearts, as previously reported
[5]; we found no signiﬁcant difference in Pgc1α mRNA expressionbetween P2.5 αMHC-Cre::VHL(ﬂ/ﬂ) and control hearts (Fig. 5D). Howev-
er, we observed a signiﬁcant decrease in Pgc1α RNAexpression in cardi-
ac ventricles from mice born in 10% ambient oxygen compared with
normoxic controls (p = 0.019, 2 tailed t-test, 4 hearts each group).
Pgc1βmRNA expression was decreased in ventricles from both αMHC-
Cre::VHL(ﬂ/ﬂ) and wild-type hypoxic mice compared with controls
(Fig. 5D). Western blotting of protein extracts from ventricles of E16.5
and P2.5 αMHC-Cre::VHL(ﬂ/ﬂ) and control mouse hearts revealed that
the pattern of Pgc1α/β protein expression broadly mirrors that of
mRNA in these hearts (Fig. 5E). This implies that Pgc1α expression in
the heart around birth is not dependent on HIF signaling, whereas
Pgc1β expression is.
Taken together, our data suggest that postnatal increases in
mitochondrial mass and changes in mitochondrial morphology are
driven by increased ambient oxygen levels and decreased HIF signaling
immediately after birth. The exact molecular mechanisms underlying
this hypoxia-dependent mitochondrial biogenesis remain unclear.
2.4. HIF signaling controls neonatal cardiac mitochondrial function
We went on to investigate the effects of high levels of HIF signaling
on mitochondrial function in the embryonic heart. It is well known
that increases in HIF1α expression in a wide variety of cell types induce
metabolic changes that lead to lower oxygen consumption [21]. We
therefore examined mitochondrial function and oxygen consumption
in primary cultures from αMHC-Cre::VHL(ﬂ/ﬂ) and control hearts, as
well as HL1 cardiomyocyte cell lines stably transfected with an shRNA
construct directed against VHL.
Fig. 3. Cardiac expression ofMFN1,MFN2 and OPA1 in the neonatal heart is affected by HIF signaling. (A–C) Quantiﬁcation of western blot of protein extract fromwild-typemouse hearts
at E16.5–P10.5, showing signiﬁcant increases in postnatal cardiac protein levels of MFN1, MFN2, OPA1 respectively (n= 3 each experiment, *P b 0.05, p value represents 2-tailed t test).
(D) Postnatal cardiac levels of MFN1, MFN2 and OPA1 are signiﬁcantly reduced in αMHC-Cre::VHL ﬂ/ﬂ hearts compared with αMHC-Cre controls (n = 6, *P b 0.05, p value represents 2-
tailed t test). Data presented asmean±SEM. (E–G)Quantitative RT-PCRof cDNA from embryonic (E18.5), postnatal (P2.5)αMHC-Cre (control) andαMHC-Cre::VHL(ﬂ/ﬂ) hearts, and adult
mercremer::VHL(ﬂ/ﬂ) following 5 days of tamoxifen induction, showing postnatal transcriptional upregulation of MFN1, MFN2 and OPA1 at birth in all cases; this rise is signiﬁcantly
attenuated in P2.5 VHL null hearts, which do not downregulate HIF signaling postnatally. Cardiac expression of MFN1, MFN2 and OPA1mRNA is not altered following cardiac-speciﬁc de-
letion of VHL. Adult mercremer::VHL(ﬂ/ﬂ) mice were given tamoxifen IP for 5 days at 30 days of age, and analyzed 30 days after the ﬁrst injection. (n = 6, *P b 0.05, **P b 0.005, p value
represents 2-tailed t test). Data presented as mean ± SEM.
344 M.T. Neary et al. / Journal of Molecular and Cellular Cardiology 74 (2014) 340–352Application of the mitochondrial uncoupler FCCP (1 μM) to cells
maximizes respiration and completely oxidizes the mitochondrial pool
of NADH, manifesting as a decrease in ﬂuorescence (taken as 0)
(Fig. 5A). Conversely, the complex IV inhibitor NaCN (1mM) suppresses
respiration by preventing NADH oxidation and allowing the NADH pool
to regenerate fully (taken as 100). The redox index is expressed as a
percentage of basal NADH autoﬂuorescence between 0 and 100 [22].
Cardiomyocytes isolated from E16.5 αMHC-Cre::VHL(ﬂ/ﬂ) hearts exhibit-
ed an increase in mitochondrial NADH redox index when compared to
controls (Figs. 6A–B) suggesting an inhibition of mitochondrialFig. 4. Binding of HIF1α to the 5’ promoters ofmitofusins is affected by hypoxia signaling in the
of canonical (N)CGTGHIF1α binding sites. (B–D) RTPCR of chromatin immunoprecipitation assa
MFN2 and OPA1 promoters from e18 hearts from αMHC-Cre control hearts, showing binding o
itation from control P2.5 cardiac chromatin revealed reduction in HIF1α binding to several sit
hearts (H–J). (Bars represent summation of three experiments, and results expressed as mu
ampliﬁed γ-crystallin primers. *p b 0.5, **p b 0.005).respiration. Interestingly, the rate of regeneration of the NADH pool in
response to NaCN addition was much slower in VHL knockdown cells
than the corresponding rate in control cells (Fig. 6A) suggesting a mild
inhibition of NADH production in the tricarboxylic acid cycle (TCA). De-
spite the slower NADH production the total mitochondrial pool of
NADH (estimated as a difference in signal between application FCCP
andNaCN)was signiﬁcantly higher than control cells (Fig. 6C). This sug-
gests that the inhibition of mitochondrial respiration in VHL null cells
(i.e. with constitutively active HIF signaling) is not due to lack of
substrate for complex I.perinatal heart. (A) Schematic of 5’ promoters of MFN1,MFN2 and OPA1 showing locations
y using anti HIF1α antiserumand primers to theHIFmotif-containing sequences inMFN1,
f HIF1α to more than one site in each promoter. (E–G) HIF1α chromatin immunoprecip-
es in all promoters, and that binding was altered in chromatin from αMHC-Cre::VHL(ﬂ/ﬂ)
ltiples of signal for non-ampliﬁed sequence. P values are 2-tailed t tests relative to non-
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Fig. 5. Hypoxia signaling controls postnatal cardiomyocyte mitochondrial biogenesis. (A) PCR of mitochondrial-encoded (COX2) and nuclear-encoded (β-globin) genes revealed an in-
crease in mitochondrial DNA at P2.5 compared with E18. This increase was not seen in αMHC-Cre::VHL(ﬂ/ﬂ) hearts (VHL null), or hearts from animals born into 10% oxygen (hypoxia)
(n = 6 hearts each group, p value represents 2-tailed t test). (B) RTPCR of cardiac cDNA isolated from neonatal hearts revealed that postnatal increases in transcription of
mitochondrial-encoded subunits of Complex 1, 4 and 5 are not seen in αMHC-Cre::VHL(ﬂ/ﬂ) hearts, or hearts fromwild-type mice born into 10% FiO2. (C) Cardiac citrate synthase activity,
a marker of mitochondrial volume, increases at birth in control hearts, but this increase is not seen in αMHC-Cre::VHL(ﬂ/ﬂ) hearts. (N = 8 each group, p = two tailed t test). (D) RTPCR
showing Pgc1α/βmRNA levels increase in the heart after birth in control but not hearts frommice born into 10% oxygen (hypoxia). mRNA levels of Pgc1β but not Pgc1αwere signiﬁcantly
reduced inαMHC-Cre::VHL(ﬂ/ﬂ)hearts comparedwithwild types. (n=6hearts each groupp value represents 2-tailed t test for all RTPCR experiments). (E)Western blots of protein extract
from P2.5 αMHC-Cre::VHL(ﬂ/ﬂ) and control hearts, showing that levels of Pgc1α in αMHC-Cre::VHL(ﬂ/ﬂ) hearts do not differ from controls, whereas Pgc1β protein levels are lower in αMHC-
Cre::VHL(ﬂ/ﬂ) hearts than controls.
346 M.T. Neary et al. / Journal of Molecular and Cellular Cardiology 74 (2014) 340–352Mitochondrial respiration is dependent on the mitochondrial mem-
brane potential (Δψm). Using live cell imaging and the ﬂuorescent dye
tetramethylrhodamine methyl ester (TMRM), we measured the Δψm,
a universal indicator of mitochondrial health and the metabolic state
of the cell. We observed a dramatic decrease in the level of Δψm in
VHL-knockdownHL1 cells (to 60% actual of control, n= 14 cells per ge-
notype) and even lower in αMHC-Cre::VHL(ﬂ/ﬂ) cardiomyocytes (to 25%
of control, n = 12 cells; Fig. 6D). In healthy cells, Δψm is maintained by
the activity of themitochondrial respiratory chain. In the event of dam-
age or an inhibition of mitochondrial respiration, cells may maintain
Δψm using ATP hydrolysis through the ATP synthase [23]. In order to
investigate the mechanism of maintenance of Δψm in hypoxic
cardiomyocytes, mitochondrial inhibitors were applied and their effects
on Δψm were observed. Application of the F0-F1-ATP synthase inhibitor
oligomycin (2 μg/ml) did not signiﬁcantly change Δψm, while subse-
quent inhibition of complex I by rotenone (1 μM) caused a rapid loss
of potential (Fig. 6E). Despite the low Δψm, VHL knockdown cells did
not depolarize in response to oligomycin but showed a small hyperpo-
larization, suggesting that the mitochondria produce ATP in conditions
of a low Δψm (Fig. 6F). Subsequent application of rotenone and FCCPled to a drop in the signal in response to the inhibitor of complex I
that was greater in VHL knockdown cells when compared to control
cells. In VHL knockdown cells, a lower response to FCCP at the end of
the experiment suggests that complex II plays a smaller part in the
maintenance of Δψm as previous application of oligomycin and rote-
none leaves complex II as the only electron donor under these condi-
tions (Fig. 6G).
Measurement of cell respiration using a SeahorseXF analyzer
showed lower levels of oxygen consumption in αMHC-Cre::VHL(ﬂ/ﬂ)
cardiomyocytes (Fig. 7A). The inhibitory effect of oligomycin (which re-
ﬂects respiration coupled to ATP production) was also signiﬁcantly
lower in VHL null cells in comparison to controls cells implying lower
levels of oxidative phosphorylation (n = 5 assays for each genotype,
experiment repeated 3 times). This difference was also reﬂected in the
maximal rate of oxygen consumption (measured after stimulation
with the uncoupler FCCP), which was also signiﬁcantly reduced in
αMHC-Cre::VHL(ﬂ/ﬂ) cardiomyocytes (Fig. 7A), implying that downregu-
lation of cardiac HIF signaling is necessary for postnatal mitochondrial
remodeling. We performed oxygen ﬂux analysis on VHL knockdown
and control HL1 cells and found a similar result (Supplementary Fig. 5).
Fig. 6. HIF signaling controls postnatal changes in mitochondrial redox state. (A) NADH autoﬂuorescence in empty-vector-transfected control and ShRNA VHL HL-1 cells in response to
FCCP (1 μM) and NaCN (1 mM). Data have been normalized and expressed as percentage of maximum. (B) NADH redox state (%) and (C) mitochondrial NADH pool (%) in control and
shRNA VHL cells. Data are presented as mean of 3 experiments compared to controls. (D) Basal mitochondrial membrane potential in control and primary cardiomyocytes from VHL
null hearts or VHL knockdown HL1 cell lines. Data presented as mean percentage compared to WT± SEM. (E, F) TMRM ﬂuorescence inWT and VHL KO primary cardiomyocytes respec-
tively after addition of oligomycin (2 μg/ml), rotenone (1 μM)and FCCP (1 μM). (G) TMRMﬂuorescence in control (WT) andVHLnull primary cultured cardiomyocytes in response to FCCP
after application of oligomycin 2 μg/ml and rotenone 1 μg/ml. Data presented as mean percentage compared to control ± SEM.
347M.T. Neary et al. / Journal of Molecular and Cellular Cardiology 74 (2014) 340–352The reduced respiration and its insensitivity to oligomycin, lower
mitochondrial membrane potential in VHL null cardiomyocytes indi-
cate that oxidative phosphorylation could be impaired in these cells.
We therefore compared the ATP levels in control and VHL knock-
down HL1 cells with the ATP sensing probe Cox AT1.03 [24,25]. Sur-
prisingly, we found no signiﬁcant difference in mitochondrial ATP
production between control (empty vector) and VHL knockdown
HL1 cells (Fig. 7B). We also investigated the impact on ATP produc-
tion of inhibiting oxidative phosphorylation (by inhibition with
oligomycin, 2 μg/ml) or glycolysis (by inhibition with iodoacetic
acid (IAA), 20 μM). Compared to empty-vector transfected controls,
the basal level of ATP in VHL knockdown cells showed no signiﬁcant
difference (n = 6) (Figs. 7C, D). Most importantly, the use of inhibi-
tors revealed that the mechanism of ATP production differs between
VHL knockdown and control cells. As expected, in control cells
oligomycin depleted all ATP and IAA had no further effect (Fig. 7C).
In VHL-knockdown cells, oligomycin induced a decrease in ATP
levels but it also signiﬁcantly induced a drop in ATP in response to
the inhibitor of glycolysis IAA (Figs. 7D-E), implying that VHL-
knockdown cells rely not only on oxidative phosphorylation but
also heavily on glycolysis for their ATP production. Interestingly,
pre-incubation of VHL-knockdown cells with substrates for mito-
chondrial respiration (5 mM glutamate, 5 mM malate, 5 mM succi-
nate and 1 mM palmitine–carnitine) did not change the level of
[ATP] but completely blocked the effect of IAA on [ATP] (Fig. 7F).
Thus, a small proportion of the glycolysis to ATP production in
VHL-knockdown cells can be inhibited by recovery of oxidative
phosphorylation by addition of mitochondrial substrates. We
suggest that provision of several substrates stimulates oxidative
phosphorylation and reduces the need for glycolysis in hypoxic
cardiomyocytes.3. Discussion
Herewe describe data supporting a novel hypothesis that the postna-
tal increase in oxygen tension encountered by the neonate acts as a phys-
iological trigger for mitochondrial maturation in the heart. We found
that mitochondrial morphology changes dramatically around birth,
with mitochondria assuming an elongated form postnatally. These
changes in mitochondrial morphology are dependent on a reduction in
cardiac HIF signaling, and that HIF-dependent changes in expression of
MFN1 and OPA1may mediate this. The postnatal increase in cardiac mi-
tochondrial biogenesis is also dependent on a decrease in HIF signaling.
Postnatal downregulation ofHIF signaling also leads to increased respira-
tory capacity and oxidative phosphorylation. This work has implications
for medical conditions such as cyanotic congenital heart disease, where
tissues are inadequately oxygenated following birth due to abnormal
cardiac anatomy. This work focuses on cardiac mitochondrial changes
around birth; it is not yet known how these relate to mechanisms regu-
lating adult cardiac mitochondrial function and morphology.
We found no evidence that the postnatal increase in transcription of
Pgc1α is dependent on a decrease in HIF-signaling, in agreement with
our earlier ﬁnding that upregulating of HIF1α in HL1 cells does not
lead to an increase in Pgc1α protein levels [10]. Our ﬁnding that the
rise in Pgc1α mRNA and Pgc1α protein levels is attenuated in mice
born into low levels of ambient oxygen agrees with the ﬁnding that
Pgc1α expression is hypoxia dependent, but HIF-independent in
mouse skeletal muscle [26]. Interestingly, the changes seen in the
heart at birth are the reverse of skeletal hypoxic adult skeletal muscle—
i.e. hypoxia in utero inhibits expression of Pgc1α. This does leave the
question open as to what does transcriptionally regulate Pgc1α in the
heart around birth. Certainly increases in expression of Pgc1α are coinci-
dent with those of MFN1 and MFN2 in the heart around birth, and the
Fig. 7. Hypoxic cardiac mitochondria generate ATP via glycolysis and the TCA cycle. (A) Mitochondrial respiration proﬁles (OCR= oxygen consumption rate) of control and VHL null primary
cardiomyocytes were obtained using the Seahorse XF Cell Mito Stress Test Kit. Data are represented as mean± S.E.M. of 5 biological replicates. (B) Quantiﬁcation of basal ATP levels in control
and VHL knockdown HL1 cells (shVHL). (C–D) Live cell measurements of ATP levels in control and shVHL HL1 cells in response to oligomycin (2 μg/ml) and iodoacetic acid (20 μM).
(E) Quantiﬁcation of the decrease in ATP levels upon oligomycin and iodoacetic acid exposure as indicated in (D). (F) Live cell measurement of ATP in shVHL HL1 cells after the addition of mi-
tochondrial substrates (5mM glutamate, 5 mMmalate, 5 mM succinate and 1mMpalmitoyl carnitine) and exposure to oligomycin as well as iodoacetic acid. Data presented asmean± SEM.
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However, our ﬁndings that postnatal increased Pgc1α transcription is
hypoxia- but not HIF-dependent, suggest parallel regulatory pathways.Our ﬁnding that postnatal levels of pgc1β in the mouse heart are
reduced in VHL null hearts supports the ﬁnding that HIF negatively reg-
ulates pgc1β expression in renal carcinoma cells [27].
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oxygen/HIF signaling, the ambient temperature of the neonate drops,
and levels of several hormones and signaling pathways change, al-
though these changes remain poorly deﬁned. Many of these changes
have been identiﬁed as stimuli to Pgc1α expression in the context of
“stress” [28], and are thus candidates for regulatory triggers for neonatal
cardiacmaturation.We are still someway away froma complete under-
standing of the physiological regulation of neonatal cardiac remodeling.
It is unclear whether the HIF system is maximally activated at 10% FiO2.
We chose this oxygen concentration as it is the lowest level before sig-
niﬁcant mortality makes analysis impossible. Death rates of wide type
neonatal mice at 10% FiO2 are still signiﬁcantly higher than cardiac
VHL null pups, however, and it is unclear whether any observed cardiac
effects in these mice are cardiac-speciﬁc rather than due to the global
effects of hypoxia.
Our understanding of mitochondrial function in the heart lags be-
hind that ofmitochondria in cell-types such as neuron, possibly because
of the difﬁculty in culturing and studying cardiomyocytes. We believe
that study of the changes occurring in the heart around birth will afford
an insight into the endogenous physiological mechanisms adapting the
embryonic heart to extremely low levels of oxygen in utero. This infor-
mation may be of use in devising novel strategies to protect vulnerable
adult cardiomyocytes, for example during myocardial infarction.
The changes in, and regulation of gene expression in the heart
around birth are not fully understood. Our chromatin immunoprecipita-
tion data suggest that there could be signiﬁcant remodeling of cardiac
chromatin immediately following birth, and that thismay beHIF depen-
dent. Oxygen-dependent chromatin modiﬁcation has been described
[29]. The role of chromatin modiﬁcation versus direct HIF1α promoter
binding in the transcriptional control of Mitofusin expression is as yet
unclear, and will be necessary to deﬁne completely the control of neo-
natal Mitofusin expression by promoter analysis. Analysis of genomic
binding sites of HIF1α led to the conclusion that HIF1α acts as a tran-
scriptional activator for the vast majority of putative targets [30]. How-
ever, someexamples of HIF1α acting as a repressor have been published
[10,27,31]. Our data suggest that HIF1α is acting as a transcriptional re-
pressor in the context of neonatal cardiac Mitofusin expression, al-
though formal proof of this is needed. We found no difference in
HIF1α protein levels in E18.5 VHL null and control hearts, implying
that theHIF system ismaximally active in the fetal heart (Supplementa-
ry Fig. 6). This, however, remains to be investigated formally. Further-
more, it should be noted that deletion of the VHL gene has HIF-
independent effects on gene expression [32]. This is therefore a poten-
tial limitation of our study.
Our data suggest that the predominantmitochondrial site of adapta-
tion to hypoxia is electron transport complex 1. Complex 1 has been
found to be a target for HIF signaling in cardiac cells [33,34]. Chronic ex-
posure of rats to low ambient levels of oxygen leads to adaptive changes
in ROS generation along with decreases in activity of mitochondrial
complexes I, II and IV. The relatively low density of mitochondria in em-
bryonic cardiomyocytes is arguably an adaptation to low levels of oxy-
gen, leading to lower ROS generation. This does raise the possibility
that therapies directed towards inhibiting cardiac mitochondrial func-
tion may be beneﬁcial in ischemic adult myocardium. Indeed, it could
be argued that the ﬁeld of ischemia protection via preconditioning
and/or opening of the mitochondrial permeability transition pore
(MPTP) is exactly this—inhibiting mitochondrial function in a similar
manner to the embryonic cardiomyocyte.
We found that ATP is generated in VHL-null cardiomyocytes pre-
dominantly by oxidative phosphorylation with a small contribution of
glycolysis. Importantly, despite the inhibition of mitochondrial respira-
tion in hypoxic cardiomyocytes, oxidative phosphorylation is not
completely inhibited, andwe hypothesize that hypoxic cardiomyocytes
are able to utilize a number of mitochondrial substrates allowing levels
of oxidative phosphorylation sufﬁcient tomaintain ATP production. Our
work outlining a novel mechanism whereby VHL-knockdown HL1 cellsgenerate ATP andmaintain an inner mitochondrial membrane gradient
on a background of constitutive hypoxia signaling provides amechanis-
tic framework for future studies investigating how fetal cardiomyocytes
are adapted to extreme hypoxia, and potential novel therapeutic
approaches to cardioprotection. We would predict that treatments
aimed at boosting mitochondrial ATP production rather than saving
oxygen might beneﬁt ischemic cells in some circumstances.
Finally, our data together with those of others, suggest that the
embryonic myocardium is adapted to function in low levels of uterine
oxygen by a number of parallel mechanisms. We have shown that
postnatal expression of the genes encoding lipid-metabolizing genes is
upregulated postnatally by an HIF-dependent mechanism [10]. Mito-
chondrial number is reduced in embryonicmyocardium relative to neo-
natal, and activity of mitochondrial complex 1 and 4 is inhibited in the
embryonic heart and hypoxic cardiac tissue. This suggests that a combi-
nation of several therapeutic strategies may be necessary to protect
ischemic adult myocardium adequately.
4. Materials and methods
4.1. Animal husbandry
All mouse experiments were carried out in compliance with institu-
tional ethical and welfare standards in accordance with Home Ofﬁce
Animal Procedures Act (1986). The transgenic mouse strain, αMHC-
Cre::VHL(ﬂ/ﬂ) on a C57BL/10 background is previously described [11].
PCR ampliﬁcation was performed on tail-derived genomic DNA to de-
termine genotype. αMHC-Cre mouse hearts were used as controls in
this study, unless otherwise stated. Tamoxifen was administered to
mercremer::VHL(ﬂ/ﬂ) andmercremer controlmice intraperitoneally dis-
solved in vegetable oil at a dose of 1 mg for 5 consecutive days starting
at 30 days old, and were analyzed 30 days after the ﬁrst tamoxifen
injection.
4.2. Electron microscopy of mitochondria
Hearts were isolated from E10.5–E18.5 embryos from timed-mated
pregnant mice, and from newborn mice, between 0.5 and 10.5 days
old. Paired tail samples were collected for PCR genotyping. Left ventric-
ular sections were prepared for electron microscopy as described
previously and imaged using a Jeol 1200EX Transmission Electron Mi-
croscope with a Gatan Orius 1000 CCD.
Mitochondrial density was calculated by the number of mitochon-
dria in a given area (128 μm2) at 2000× magniﬁcation. The percentage
area occupied bymitochondria was estimated by the densitymultiplied
by the average length and width of the mitochondria, divided by the
image area. An average over ten pictures was taken for each heart and
three hearts were used per time point. Pictures were taken by serial
panning and the user was blinded to the sample type.
4.3. Live mitochondrial imaging
Hearts were isolated from E10.5–E18.5 embryos from timed-mated
pregnant mice, and from new born mice, between 0.5 and 10 days old.
Paired tail sampleswere collected for PCR genotyping. Heartswere indi-
vidually placed in a labeled tube containing 300 μl of warm 1 mg/ml
Collagenase II solution (Worthington Chemicals), which was then
transferred to a shaking incubator (37 °C) for 10 min. Collagenase was
then removed and the hearts washed three times in warm Claycomb
medium (Sigma-Aldrich). MitoTracker green (Life technologies), a
green-ﬂuorescent mitochondrial stain, was prepared to a 1 μM DMSO
solution as per the manufacturer's speciﬁcations, and added to tissue
culture medium at a concentration of 0.2 μl/ml. 500 μl of medium was
transferred to the hearts in sterile tubes and a p1000 Pasteur pipette
was used to disrupt the tissue and disaggregate the cells until there
were no visible clumps of cells. The cells were plated onto a glass-
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the volume of medium was made up to 2 ml total. The plate was incu-
bated at 5% CO2 and 37 °C for 45 min after which the medium was
washed and replaced with phenol-red free Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM). A Deltavision RT system based on an inverted Olym-
pus IX70 microscope (Applied Precision Inc.), inside a heated chamber
(Solent) at 37 °C, was used to capture single cell images using the Fluo-
rescein IsothioCyanate (FITC) excitation and emitter ﬁlters and a 100×
oil objective lens. MitoTracker Green signal is not sensitive to changes
of mitochondrial conditions including membrane potential and redox
status. Between 20 and 30 cells were imaged per heart sample. Images
were randomized, anonymized, and then scored blindly and indepen-
dently by two experts in mitochondrial morphology as either predomi-
nantly fragmented or fused. The scores were averaged.
4.4. Western blotting
Hearts from embryos and neonatal mice were dissected in cold PBS.
Hearts were homogenized in homogenization buffer (10% weight:
volume) (PBS supplemented with protease and phosphatase inhibitors,
Thermo Scientiﬁc). Samples were boiled and denatured in loading buff-
er containing 5% 2-mercaptoethanol (Invitrogen) and run on a 10% SDS
PAGE gel. Samples were transferred to PVDF membrane and probed
with antibodies for MFN1 (Abcam, UK, cat. no. ab57602), MFN2
(Abcam, UK, ab124773) OPA1 (Abcam, UK, ab90857) and DRP1 (Santa
Cruz, USA cat. no. sc-271583). Blots were developed using ECL and
hyperﬁlm (GE Healthcare, UK) and scanned before analysis using
Image J.
4.5. Chromatin immunoprecipitation
This was carried out as previously described [10], using 4 μg rabbit
anti-mouse HIF1α antibody (NB100-134, Novus Biochem). We per-
formed immunoprecipitation for each promoter site in e18 cardiac
chromatin using an isotype control IgG (Abcam ab13347000. We
found no signiﬁcant speciﬁc binding of this antibody to any promoter
site.
4.6. Neonates raised in hypoxia versus normoxia
Pregnant F1 (CBA/Ca x C57BL/10) females were sacriﬁced at 18 days
post coitus. The embryos were removed and fostered onto a Parkes
mouse, which had littered the previous day. Neonates were raised by
a foster mother for 24 h in either normoxia or in a hypoxic chamber
(Custom Glovebox, Biospherix) maintained at 10% O2. Prior to this, fos-
ter mothers were acclimatized to increasing hypoxia for at least three
days preceding the experiment, whereas the dam carrying the experi-
mental neonates was maintained in normoxia until she was sacriﬁced
and embryos removed. This eliminatedmaternal and prenatal exposure
to hypoxia which may have affected postnatal phenotypes.
4.7. Citrate synthase activity assay
Hearts were snap frozen, and after PCR genotyping homogenized
and subjected to colorimetric assay for citrate synthase (Biovision,
California, USA) as per manufacturer’s instructions. Lowry protein
assay was performed on the cardiac homogenate (BioRad). Results
were normalized to protein content.
4.8. Gene expression studies
Immediately after dissection in cold PBS, hearts were snap frozen in
liquid nitrogen and stored at−80 °C. RNA was extracted from hearts
using Trizol reagent (Invitrogen) according to the manufacturer's in-
structions. CDNA was prepared from RNA samples using Superscript
III and random primers (Invitrogen). Quantitative RT-PCR was carriedout using an ABI Prism 7000 cycler (Applied Bio systems) with the
cDNA equivalent to 30 ng of total RNA per reaction using SYBR green
(Thermo Scientiﬁc), with 18 s mRNA as the normalizing control. All
PCR primers were purchased from Qiagen. Primers used Complex I;
NDUF8, Complex 4 mtCOX2, Complex 5 ATP5a [35].4.9. Embryonic cardiomyocyte isolation
Embryonic cardiac myocytes were isolated from E16–18 embryos
from timed-pregnantmice. Themother was sacriﬁced by cervical dislo-
cation and embryos were taken and stored at room temperature in
freshly prepared ADS buffer (116 mM NaCl, 5.4 mM KCL, 20 mM
HEPES, 0.8 mM NaH2PO4, 405.7 μMMgSO4, 5.5 mM glucose, pH 7.35).
Hearts from each embryo were excised and rinsed in ADS buffer before
they were stored in labeled 1.5 ml Eppendorf tubes. Tails samples were
also obtained for PCR analysis. Tissue culture dishes (6 well plates or
Seahorse plates) were coated with 1% gelatin (Difco) during the isola-
tion steps.
The following stepswere carried out under tissue culture conditions:
Hearts were minced and serially digested in 1 ml digestion buffer (ABS
buffer) containing 1 mg/ml Collagenase II (Worthington Chemicals)
and 0.5 mg/ml Pancreatin (Sigma-Aldrich) in a shaking incubator set
at 37 °C for 15min.Myocyteswere not removed from the ﬁrst digestion
therefore the supernatant from the ﬁrst digest was discarded without
removing the hearts. Fresh digestion buffer was added to each heart
sample and left to incubate at 37 °C for 10 min. After this incubation,
the digest was removed and transferred to 15 ml Falcon tubes contain-
ing 2ml Fetal Calf serum (FCS) to stop the enzymic reaction. The super-
natant collected from two digests were centrifuged at 1000 r.p.m for
3 min, the solution was discarded and the cell pellet was resuspended
in fresh FCS. These incubation and centrifugation steps were repeated
six to eight times until the cardiac myocytes were completely removed
and the heart tissue was reduced to a single matrix conglomerate.
The ﬁnal cell pellet from each heart was resuspended in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) containing 10% FCS and penicillin
(50 U/ml), streptomycin (50 μg/ml) (Invitrogen). Fibroblasts were
allowed to attach for 30 min and the non-adherent (myocyte) fraction
was plated into either 6 well dishes containing 22 mm glass coverslips
(VWR) for mitochondrial function analysis or Seahorse plates for oxy-
gen consumption analysis. After 24 h, themyocytes formed amonolayer
of spontaneously beating cells; the medium was removed and replaced
withDMEMcontaining1% FCS and 1% P/S before further analysis. Hearts
from Cre positive or VHL ﬂoxed embryos were used as controls to com-
pare against mutant VHL hearts.4.10. ShRNA VHL stable cell lines
HL-1 cells were transfected with shRNA construct directed against
VHL mRNA using FugeneHD (Invitrogen) according to manufacturer's
instructions. 48 h after transfection, Claycomb medium was supple-
mented with 0.4 mg/ml G148 in order to select clones overexpressing
shRNA VHL. Individual clones were picked and qRT-PCR and Western
Blot veriﬁed expression levels of VHL. For oxygen consumption rate
and mitochondrial function experiments, neomycin was removed sev-
eral passages before analysis. An HL1 line stably expressing an empty
vector was used as control in these studies, unless otherwise stated.4.11. Oxygen consumption
A Seahorse Bioscience Instrument was used tomeasure oxygen con-
sumption rate as per manufacturer's instructions [36]. For a detailed
protocol, please refer to Breckenridge et al. 2013 [10]. All readings
were normalized to protein content, by performing a Lowry protein
content assay on wells following completion of the Seahorse assay.
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The redox state of mitochondrial NADH is a function of respiratory
chain activity and substrate turnover. We measured the resting level
of NADH autoﬂuorescence in the cells, which was then expressed as
the ‘redox index’, a ratio of the maximally oxidized and maximally re-
duced signals [37]. The dynamic range of the signals was deﬁned by
obtaining the maximally oxidized signal following the response to
1 μM FCCP (which stimulates maximal respiration and fully oxidizes
the mitochondrial NADH pool). In these conditions, mitochondrial
NADH is taken as fully oxidized and deﬁned as 0%. The maximally re-
duced signal was then deﬁned as the response to 1 mM NaCN (which
fully inhibits respiration), preventing NADH oxidation, and so promot-
ing maximal mitochondrial NADH reduction. In these conditions
NADH is taken as 100% reduced. NADH autoﬂuorescencemeasurements
were obtained from ShRNA-VHL cells.4.13. Measurement of mitochondrial redox state
NADH autoﬂuorescence was measured using an epiﬂuorescence
inverted microscope equipped with a 20× ﬂuorite objective. Excitation
light at a wavelength of 350 nmwas provided by a Xenon arc lamp, the
beam passing through a monochromator (Cairn Research, Kent, UK).
Emittedﬂuorescence lightwas reﬂected through a 455 nm long-passﬁl-
ter to a cooled CCD camera (Retiga, QImaging, Canada) and digitized to
12 bit resolution. Imaging data were collected and analyzed using soft-
ware from Andor (Belfast, UK).4.14. Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (Δψm) is an indicator of mito-
chondrial state. In these experiments tetramethylrhodamine
methylester (TMRM) is used in the ‘redistribution mode’ to assess
Δψm, and therefore a reduction in mitochondrial localized TMRM ﬂuo-
rescence represents mitochondrial depolarization. We measured Δψm,
in shRNA VHL knockdown cell lines and in primary cultures. For mea-
surements of ΔΨm, cells were plated on 22 mm glass coverslips and
loaded for 40 min at room temperature with 25 nM TMR (Invitrogen)
in a HEPES buffered saline solution (HBSS) composed of 156 mM NaCl,
3 mMKCl, 2 mMMgSO4, 1.25 mMKH2PO4, 2 mM CaCl2, 10mM glucose
and 10 mM HEPES; pH adjusted to 7.35 with NaOH. The dye remained
present in themedia at the time of recording and is used in the redistri-
bution mode. Therefore a reduction in TMRM ﬂuorescence represents
Δψm depolarization. Confocal images were obtained using a Zeiss 710
VIS CLSMequippedwith aMETAdetection systemand a 40× oil immer-
sion objective. TMRMwas excited using the 560 nm laser line and ﬂuo-
rescence was measured above 580 nm. For basal ΔΨm measurements,
Z-stack images were obtained by confocal microscopy and analyzed
using Zeiss software [22]. For measurements of ATP, the cells were
transfected for 24 h with the ATP sensing probe Cox AT1.03 using
Lipofectamine 2000 (Qiagen) according to manufacturer’s instructions
[24,25].4.15. Fluorescence measurements
NADH autoﬂuorescence was determined with excitation at
351 nm and emission at 375–470 nm [22]. Measurements of ATP
levels with Cox AT1.03 were obtained using measurement of ﬂuores-
cence resonance energy transfer by exciting the cyan ﬂuorescent
protein at 405 nm (measured at 460 to 510 nm), used to excite
yellow fluorescent protein, measured from 515 to 580 nm [24]. All
data presented were obtained from at least 5 coverslips and 2–3
different cell preparations.4.16. Statistical analysis
Statistical analysis was performed with Origin 8 (Microcal Software
Inc., Northampton, MA, USA) software. Student’s t-test was applied.
Means expressed ± the standard error of the mean (SEM).
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